Morgan Stanley Lowers Sherwin-Williams (NYSE:SHW) Price Target to $405.00

Sherwin-Williams (NYSE:SHW - Free Report) had its target price reduced by Morgan Stanley from $450.00 to $405.00 in a report issued on Tuesday morning,Benzinga reports. They currently have an overweight rating on the specialty chemicals company's stock.

SHW has been the subject of several other research reports. Wells Fargo & Company upped their price target on shares of Sherwin-Williams from $350.00 to $400.00 and gave the company an "equal weight" rating in a research report on Tuesday, October 15th. BMO Capital Markets increased their price objective on Sherwin-Williams from $400.00 to $425.00 and gave the stock an "outperform" rating in a research report on Monday, September 30th. Royal Bank of Canada dropped their target price on Sherwin-Williams from $455.00 to $446.00 and set an "outperform" rating on the stock in a report on Thursday, October 24th. Zelman & Associates raised Sherwin-Williams to a "strong-buy" rating in a report on Friday, January 17th. Finally, Evercore ISI boosted their price objective on shares of Sherwin-Williams from $400.00 to $420.00 and gave the company an "outperform" rating in a research note on Thursday, November 7th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat, Sherwin-Williams has a consensus rating of "Moderate Buy" and a consensus target price of $400.65.

Sherwin-Williams Stock Up 0.1 %

NYSE:SHW traded up $0.23 during midday trading on Tuesday, reaching $364.40. The company had a trading volume of 1,338,848 shares, compared to its average volume of 1,573,073. The company has a current ratio of 0.83, a quick ratio of 0.51 and a debt-to-equity ratio of 1.97. The firm has a market capitalization of $91.77 billion, a price-to-earnings ratio of 36.29, a PEG ratio of 2.78 and a beta of 1.22. The stock's fifty day simple moving average is $361.00 and its 200-day simple moving average is $362.74. Sherwin-Williams has a 12-month low of $282.09 and a 12-month high of $400.42.

Insiders Place Their Bets

In other Sherwin-Williams news, SVP Mary L. Garceau sold 15,770 shares of the stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $397.92, for a total value of $6,275,198.40. Following the completion of the sale, the senior vice president now owns 29,205 shares of the company's stock, valued at $11,621,253.60. This trade represents a 35.06 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Gregory P. Sofish sold 2,565 shares of the business's stock in a transaction on Monday, November 18th. The stock was sold at an average price of $378.63, for a total transaction of $971,185.95. Following the transaction, the senior vice president now directly owns 6,329 shares in the company, valued at approximately $2,396,349.27. The trade was a 28.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.60% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Sherwin-Williams

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Kestra Private Wealth Services LLC increased its holdings in Sherwin-Williams by 22.0% in the fourth quarter. Kestra Private Wealth Services LLC now owns 10,355 shares of the specialty chemicals company's stock valued at $3,520,000 after buying an additional 1,864 shares during the last quarter. Empowered Funds LLC lifted its position in shares of Sherwin-Williams by 7.1% in the 4th quarter. Empowered Funds LLC now owns 5,610 shares of the specialty chemicals company's stock worth $1,907,000 after buying an additional 371 shares during the last quarter. Kingsview Wealth Management LLC grew its position in shares of Sherwin-Williams by 11.1% during the 4th quarter. Kingsview Wealth Management LLC now owns 1,067 shares of the specialty chemicals company's stock valued at $363,000 after buying an additional 107 shares during the last quarter. Apollon Wealth Management LLC lifted its holdings in Sherwin-Williams by 19.6% in the fourth quarter. Apollon Wealth Management LLC now owns 4,476 shares of the specialty chemicals company's stock worth $1,522,000 after acquiring an additional 732 shares during the last quarter. Finally, Vest Financial LLC grew its holdings in shares of Sherwin-Williams by 6.8% during the fourth quarter. Vest Financial LLC now owns 156,981 shares of the specialty chemicals company's stock valued at $53,363,000 after purchasing an additional 10,017 shares during the last quarter. 77.67% of the stock is currently owned by hedge funds and other institutional investors.

About Sherwin-Williams

The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.